| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT06533358 A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI |
overall status: Recruiting → Unknown |
| 2026-07-25 | NCT07284043 A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary… |
Trial completed |
| 2026-07-25 | NCT07284043 A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary… |
date change Primary completion moved earlier: 2026-11 -> 2026-05-14 |
| 2026-07-25 | NCT07284043 A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary… |
date change Completion moved earlier: 2027-03 -> 2026-05-14 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07122401 | Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism | Secondary Hyperparathyroidism, Chronic Kidney Disease | Recruiting |
| Phase 2 | |||
| NCT06976177 | Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT)… | Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis | Recruiting |
| NCT07205328 | A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke | Acute Ischemic Stroke | Recruiting |
| Phase 1 | |||
| NCT07024160 | Phase I Study of MT1011 Injection in Healthy Subjects | Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation | Recruiting |